Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,016.66 -19.38 (-1.87%)
Streaming Delayed Price Updated: 9:53 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
News headline image
Eli Lilly Advances AI And Access: Supercomputer With NVIDIA, Zepbound Via Walmart ↗
Eli Lilly partners with NVIDIA to build a powerful AI supercomputer and teams up with Walmart to expand affordable Zepbound access nationwide. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Nvidia Shatters Records with $5 Trillion Market Cap, Cementing AI Revolution Leadership
Santa Clara, CA – October 29, 2025 – In a historic moment for the technology sector, Nvidia (NASDAQ: NVDA) has officially achieved an unprecedented $5 trillion market capitalization, becoming the first... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Nvidia's 2 Surprises; NVDA Soars On Trump-Fueled Hopes of China Blackwell Sales; Fed In Focus ↗
Two Nvidia Shockers Please click here for an enlarged chart of NVIDIA Corp (NASDAQ:NVDA). 
Via Benzinga
Topics Economy
News headline image
Earnings Outlook For Eli Lilly ↗
 
Via Benzinga
News headline image
Nvidia's AI Reign: Fueling Market Gains and Forging a New Industrial Revolution
Nvidia (NASDAQ: NVDA) stands as the undisputed titan of the artificial intelligence (AI) era, its stock performance a primary catalyst for the recent, unprecedented surge in global financial markets.... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
Via Investor Brand Network
News headline image
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOVA),(NYSE:MRK),(NYSE:LLY),(NYSE:JNJ) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Eli Lilly Partners With Walmart To Expand Access To Popular Weight-loss Drug ↗
Zepbound vials will be offered for pick-up at Walmart pharmacies nationwide by mid-November. 
Via Stocktwits
News headline image
1 Incredible Reason to Buy Novo Nordisk Stock (NVO) in November -- or Sooner ↗
It offers compelling weight-loss drugs -- and a compelling stock price, too. 
Via The Motley Fool
News headline image
Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026? ↗
This stock has caught fire after some recent events, but how long will that last? 
Via The Motley Fool
News headline image
Eli Lilly (LLY) To Report Earnings Tomorrow: Here Is What To Expect
Global pharmaceutical company Eli Lilly (NYSE:LLY) will be announcing earnings results this Thursday before market open. Here’s what investors should know. 
Via StockStory
News headline image
1 Undervalued Growth Stock Down 8% to Buy Before 2026 ↗
This momentary pullback represents an excellent opportunity to buy this high-flying stock. 
Via The Motley Fool
Topics World Trade
News headline image
Eli Lilly Partners With Nvidia To Build Pharma’s Most Powerful AI Supercomputer ↗
The Nvidia-powered system aims to cut drug development times and boost innovation. 
Via Talk Markets
Topics Artificial Intelligence
News headline image
Why Nvidia (NVDA) Stock Is Up Today
Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA) jumped 5.2% in the afternoon session after CEO Jensen Huang laid out an overwhelmingly bullish case for the company's future at a... 
Via StockStory
Topics Artificial Intelligence Government World Trade
News headline image
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety ↗
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women. 
Via Benzinga
Topics Lawsuit
News headline image
Why NeoGenomics (NEO) Stock Is Trading Up Today
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 1.1% in the morning session after it reported third-quarter 2025 results where revenue beat Wall Street's expectations. 
Via StockStory
Topics World Trade
News headline image
If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These ↗
These two have been neglected by Wall Street too much. 
Via The Motley Fool
News headline image
Eli Lilly & Co (NYSE:LLY) Presents a High Growth Momentum and Technical Breakout Opportunity ↗
Eli Lilly (LLY) is a top growth momentum stock with accelerating earnings, strong technical ratings, and a positive breakout setup for investors. 
Via Chartmill
News headline image
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Peering Into Eli Lilly and Co's Recent Short Interest ↗
 
Via Benzinga
News headline image
BDF-GESTION Trims Its Eli Lilly (LLY) Stake by 4,149 Shares ↗
BDF-GESTION Trims Its Eli Lilly (LLY) Stake by 4,149 Shares 
Via The Motley Fool
News headline image
What Is 1 of the Best Pharmaceutical Stocks to Buy Now? ↗
This pharma giant is entering the rapidly expanding market for weight loss drugs. 
Via The Motley Fool
News headline image
Down 15%, Should You Buy the Dip on Eli Lilly? ↗
Lilly's stock has pulled back from its 2024 highs, but that doesn't mean the shares are cheap enough to buy. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Viking Therapeutics: High Risk, High Reward Play ↗
Via MarketBeat
News headline image
Should You Buy Eli Lilly Stock Before Oct. 30? ↗
Long-term investors don't need to rush to buy Eli Lilly stock. 
Via The Motley Fool
News headline image
Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal ↗
Avidity Biosciences (NASDAQ: RNA) shares soar as Novartis (NYSE: NVS) agrees to acquire them for $12 billion in cash. 
Via Benzinga
News headline image
BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher? ↗
The clinical-stage biotech is working on a new type of weight management drug. 
Via The Motley Fool
News headline image
Eli Lilly And Co. Stock: Gains As $12.47-Per-Share Adverum Biotech Deal Expands Gene Therapy Portfolio ↗
Eli Lilly stock rises as $12.47-per-share Adverum Biotech deal boosts its gene therapy ambitions and expands ophthalmology pipeline. 
Via Talk Markets
News headline image
Eli Lilly's New Ebglyss Results Back Flexible Treatment Options For Atopic Dermatitis ↗
Eli Lilly reports new data showing sustained efficacy for Ebglyss with less frequent dosing and strong long-term results for Olumiant in hair regrowth. 
Via Benzinga
News headline image
Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections ↗
Lilly (LLY) to acquire Adverum Biotechnologies (ADVM) for $12.47 per share, with potential CVR payments tied to future milestones. 
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.